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Abstract: Decreased nitric oxide (NO) availability due to obesity and endothelial 
dysfunction might be causally related to the development of lifestyle-related diseases such 
as insulin resistance, ischemic heart disease, and hypertension. In such situations, instead 
of impaired NO synthase (NOS)-dependent NO generation, the entero-salivary  
nitrate-nitrite-NO pathway might serve as a backup system for NO generation by 
transmitting NO activities in the various molecular forms including NO and protein  
S-nitrosothiols. Recently accumulated evidence has demonstrated that dietary intake of 
fruits and vegetables rich in nitrate/nitrite is an inexpensive and easily-practicable way to 
prevent insulin resistance and vascular endothelial dysfunction by i ncreasing  
the NO availability; a NO-rich diet may also prevent other lifestyle-related diseases,  
including osteoporosis, chronic obstructive pulmonary disease (COPD), and cancer.  
This review provides an overview of our current knowledge of NO generation  
through the entero-salivary pathway and discusses its safety and preventive effects on  
lifestyle-related diseases. 
Keywords: lifestyle-related disease; nitric oxide (NO); nitrate; nitrite; insulin resistance; 
ischemia/reperfusion injury; chronic obstructive pulmonary disease (COPD);  
osteoporosis; cancer 
 
  
OPEN ACCESS 
 
Nutrients 2015, 7 4912 
 
1. Introduction 
Health problems, such as insulin resistance, cardiovascular disease, osteoporosis, and cancer share 
some common risk factors, including unhealthy and excessive nutrition, a lack of physical activity, 
smoking and heavy drinking [1]. So-called lifestyle-related diseases are now the leading causes of 
mortality and morbidity in developed countries [2]. Healthy diets and exercise training are low-cost 
and easily-practicable lifestyle changes to be recommended for patients with these conditions before 
starting pharmacological therapy. Recent prospective and epidemiologic studies have shown that 
among the various foods, green leafy vegetables are undoubtedly protective against coronary heart 
disease, hypertension [3–6], and ischemic stroke [7]. This may be because vegetables and fruits rich in 
nitrate can provide a physiological substrate for reduction to form nitrite and nitric oxide (NO). The 
beneficial effects of these foods on the diseases resulting from circulatory disturbances are attributed to 
the cyclic guanosine monophosphate (cGMP)-dependent actions of NO, including vasodilation and 
vascular endothelial protection from platelet aggregation and leukocyte adhesion [8]. However, in 
addition to these classical functions of NO, recent studies have indicated novel functions for NO 
through cGMP-independent and protein S-nitrosylation-dependent intracellular signaling pathways [9].  
S-nitrosylation is associated with the activation of transcription factors, the regulation of a  
number of signal transduction molecules [10] and redox protein modification [11], mitochondrial  
functions [12,13], and cell apoptosis [14], which could explain how the dietary nitrate exerts 
preventive effects against the development of lifestyle-related metabolic, inflammatory, and proliferative 
disorders. This review provides an overview of our current knowledge of NO production through the 
dietary nitrate-nitrite-NO pathway and its physiological aspect, then discusses the safety and efficacy 
of dietary nitrate, as well as its preventive effects on lifestyle-related diseases. 
2. The Dietary Nitrate-nitrite-NO Pathway and Its Physiological Aspect 
In addition to endogenous NO generation through the L-arginine-NO synthase (NOS) pathway, NO 
is also generated through the NOS-independent nitrate-nitrite-NO pathway [15] (Figure 1). Green leafy 
vegetables such as lettuce, spinach and beetroot all contain high concentrations of nitrate [16]  
(Table 1). Vegetables account for 60%–80% of the daily nitrate intake in a Western diet [17], and 
substantial elevations in the plasma nitrite levels can occur through increasing the dietary nitrate  
intake [18]. One serving of such a vegetable contains more nitrate than what is endogenously 
generated by NOS isoforms during a full day in humans [19]. As shown in Figure 2, t he ingested 
dietary nitrate is absorbed in the upper gastrointestinal tract and reaches the peak plasma level around 
30–60 min after ingestion [20] (Table 2). Approximately 25% of the absorbed nitrate is delivered to the 
salivary gland and secreted into saliva in the oral cavity [21], which is then reduced to nitrite by 
commensal anaerobic bacteria on the tongue [22]. In the acidic environment of the stomach, part of the 
swallowed nitrite is immediately protonated to nitrous acid (NO2− + H+ → HNO2), then decomposed to 
form a variety of nitrogen oxides such as NO, nitrogen dioxides (NO2), and dinitrogen trioxide (N2O3) 
(2 HNO2 → N2O3 + H2O, N2O3 → NO + NO2) [23]. These nitrogen oxides form additional bioactive 
adducts, such as S-nitrosothiols and N-nitrosoamines, following reactions with protein thiols and 
amines, respectively, in the dietary products. In particular, the NO production in the stomach is greatly 
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enhanced in the presence of dietary polyphenols [24] and ascorbic acid [15], whereas because of its 
lower stability and shorter half-life relative to S-nitrosothiols, the released NO in the stomach is 
thought to locally contribute to increasing the gastric mucosal blood flow and mucous thickness to 
ensure the normal gastric physiology, and serves as t he first-line host defense against swallowed 
pathogens [25,26]. However, some of the nitrite escapes the protonation in the acidic milieu of the 
stomach and enters the systemic circulation, and then reaches the peripheral organs, including skeletal 
muscles, where it acts in an endocrine manner to exert NO-like activity [18] (Figure 2). Because the 
plasma levels of nitrite are highly dependent on the amount of salivary nitrate and its reduction to 
nitrite, the use of an antibacterial mouthwash [27] and frequent spitting of saliva consequently decrease 
the plasma levels of nitrite [20]. 
 
Figure 1. The NO pathways. NO is originated from the diet, drugs, and the endogenous 
NOS enzyme. The activities of NO are exerted through cGMP-dependent and independent 
ways. NO donor drugs, such as nitroglycerin and sodium nitroprusside, directly release 
NO. NOS endogenously generates NO, which is linked to the cGMP-dependent functions 
of NO. Dietary nitrate/nitrite produce NO and S-nitrosothiol, mainly for  
cGMP-independent functions. NO: nitric oxide, NOS: NO synthase, cGMP: cyclic 
guanosine monophosphate. 
Table 1. Nitrate and nitrite contents of food products. 
Food product 
Nitrate concentration (mg/100 g) Nitrite concentration (mg/100 g) 
Reference 
Mean Range Mean Range 
Beets 275.6 168–359 1.00 0.21–2.98 
[16] 
Spinach 233.3 53.5–366 0.70 0.0–1.29 
Radishes 168.0 76.4–250 0.01 0.0–0.1 
Celery 154.4 31.6–332 0.16 0.0–0.52 
Lettuce 85.0 7.9–217.1 0.06 0.001–0.97 
Iceberg lettuce 78.6 34.7–108 0.02 0.0–0.17 
Mushroom 59.0 1.9–8.5 0.80 0.0–3.8 
Cabbage 57.3 19.3–97.6 0.24 0.0–1.26 
Broccoli 39.4 2.9–114 0.06 0.001–0.95 
Green beans 38.6 16.5–61.1 0.05 0.0–0.25 
Strawberries 17.3 10.5–29.3 0.20 0.0–0.71 
Banana 13.7 8.8–21.4 0.21 0.0–0.95 
Green pepper 3.3 0.8–5.5 0.04 0.0–0.3 
NO donors NOS 
(drugs) (endogenous)
Nitrate 
(dietary)
NO Nitrite
cGMP-dependent 
(vasorelaxation, etc.)
cGMP-independent
(signaling and posttranslational 
modifications, etc.)
S-nitrosothiol
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Table 1. Cont. 
Food product 
Nitrate concentration (mg/100 g) Nitrite concentration (mg/100 g) 
Reference 
Mean Range Mean Range 
Spinach 741.0 - 0.02 - 
[28] 
Mustard greens 116.0 - 0.003 - 
Salad mix 82.1 - 0.13 - 
Cole slaw 55.9 - 0.07 - 
Broccoli 39.5 - 0.07 - 
Tomato 39.2 - 0.03 - 
Vegetable soup 20.9 - 0.001 - 
Hot dog 9.0 - 0.05 - 
Bacon 5.5 - 0.38 - 
Banana 4.5 - 0.009 - 
Pork tenderloin 3.3 - 0.0 - 
Bacon nitrite-free 3.0 - 0.68 - 
French fries 2.0 - 0.17 - 
Ham 0.9 - 0.89 - 
Fruit mix 0.9 - 0.08 - 
Orange 0.8 - 0.02 - 
Apple sauce 0.3 - 0.008 - 
Ketchup 0.1 - 0.13 - 
Carrots 0.1 - 0.006 - 
 Nit rate concentration (mg/L) Nit rite concentration (mg/L) 
Carrot juice 27.55 - 0.036 - 
Vegetable juice * 26.17 - 0.092 - 
Pomegranate juice 12.93 - 0.069 - 
Cranberry juice 9.12 - 0.145 - 
Acai juice 0.56 - 0.013 - 
Green tea 0.23 - 0.007 - 
* V8; Campbell Soup Co (Camden, NJ, USA); Table is reproduced from the reference [16] and [28]. 
Table 2. Saliva and plasma levels of nitrite, nitrate, and S-nitrosothiol before and 30 min 
after oral administration of sodium nitrate (10 mg/kg) in healthy volunteers. 
  0 Min 30 Min 
Saliva 
Nitrite (μM) 104 ± 21 713 ± 150 
Nitrate (mM) 0.19 ± 0.03 8.2 ± 1 
S-NO (nM) 25 ± 9.8 297 
Plasma 
Nitrite (μM) 123 ± 19 229 ± 46 
Nitrate (mM) 30 ± 4 432 ± 44 
S-NO (nM) 6.3 ± 1.4 No significant change 
Data from reference 20, S-NO: S-nitrosothiol. 
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Figure 2. The entero-salivary nitrate-nitrite-NO pathway. Twenty-five percent of the 
ingested dietary nitrate is recycled to the saliva, and 20% of the nitrate in saliva is 
converted to nitrite by oral commensal bacteria. Approximately 5% of the originally 
ingested nitrate is swallowed into the stomach, and provides for NO activities in various 
forms. (1) NO for local vasodilation, mucus formation, and antimicrobial activity; (2)  
N-nitrosoamines for local carcinogenesis; (3) Nitrite for nitrite pool and transnitrosylation in 
the peripheral tissues; (4) S-nitrosothiols for transnitrosylation in the peripheral tissues. 
The plasma nitrite which reaches peripheral tissues is stored in various organs. Although there have 
been few reports dealing with the tissue levels of nitrate/nitrite following dietary nitrate 
supplementation in humans, animal studies show that dietary nitrate certainly increases the tissue 
levels of nitrate/nitrite following increase in the plasma levels of nitrate/nitrite (Table 3), which 
accordingly exerts therapeutic efficacy for animal models of various disease conditions. Interestingly, 
while acute dietary nitrate intake increases the plasma levels of nitrite in rodents and humans [10,20], 
chronic dietary nitrate intake does not always increase the plasma and tissue levels of nitrite, but 
increases the tissue levels of nitrate and S-nitrosylated products (Table 3). Although the  
mechanism underlying this finding is yet to be clarified, there might be some redox equilibrium of  
nitrate-nitrite-NO after chronic dietary nitrate intake, resulting in oxidation or reduction of the tissue 
nitrite to form nitrate or S-nitrosylated species, respectively. On the other hand, animal models 
chronically fed a diet deficient in nitrate/nitrite exhibit significantly diminished plasma and tissue 
levels of nitrate/nitrite, resulting in increased ischemia-reperfusion injuries in heart and liver  
compared with the animal models fed a normal diet [29,30]. These results suggest that dietary nitrate  
intake is important in the maintenance of steady-state tissue levels of nitrate/nitrite for  
NO-mediated cytoprotection. 
Various enzyme/protein-dependent reductions to NO have been proposed under physiological  
and pathological conditions, which include deoxyhemoglobin [31], deoxymyoglobin in the skeletal, 
vascular [32], and cardiac muscles [33], xanthine oxidase in endothelial cells, aldehyde oxidase, 
aldehyde dehydrogenase 2 [34], cytochrome P-450, and mitochondrial nitrite reductases (such as 
Nitrate 
(100%)
Local and systemic 
actions in the forms of
(1) NO
(2) N-nitrosoamines
(3) Nitrite
(4) S-nitrosothiols
Nitrate 
(25%)
Nitrate (75%) 
excreted in urine
Salivary
gland
Nitrite 
(5%)
Reduced to nitrite
by commensal bacteria 
on the tongue
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mitochondrial electron transport complexes) in all cells. In contrast to NOS-dependent NO production, 
which requires molecular oxygen, this nitrite reduction to NO is enhanced under hypoxic and acidic 
conditions. Because the nitrite-reducing factors are rich in skeletal muscles, tissue hypoxia during 
submaximal exercise kinetically favors nitrite reduction to NO, thus providing an alternative NO 
source for vascular dilation and efficient O2 consumption in the working muscles [35,36]. 
Table 3. The effects of chronic dietary nitrate supplementation on tissue levels of 
nitrate/nitrite and therapeutic efficacy for experimental animal models. 
Animal Model Dietary Nitrate Tissues Effects of Dietary Nitrate References 
Uninephrectomized 
hypertension rat 
with high-salt diet. 
Diets with 0.1 mM 
and 1 mM  
nitrate/kg/day for  
8–11 weeks. 
Kidney  
Heart  
Liver 
Increase in plasma and tissue 
levels of nitrate and tissue levels 
of nitrosylation products. 
Reduction of oxidative stress and 
attenuation of renal injury, 
hypertension, cardiac hypertrophy 
and fibrosis. 
[37] 
C57BLK6 male 
mice with  
hypoxia-induced 
pulmonary 
hypertension. 
0.6 mM, 15 mM, 
and 45 mM 
nitrate/L in drinking 
water for 3 weeks. 
Lung 
Increase in plasma and lung levels 
of nitrite and cGMP. Reduction of 
right ventricular pressure and  
hypertrophy, and pulmonary 
vascular remodeling. 
[38] 
Male Wistar rat  
with hypoxic  
heart damage. 
0.7 mM/L nitrate in 
drinking water for  
2 weeks. 
Heart 
Increase in plasma levels of nitrate 
and tissue levels of nitrite. Alleviation 
of metabolic abnormalities in the 
hypoxic heart. Improvement of 
myocardial energetics. 
[39] 
Although elevated plasma levels of nitrite certainly affect the cGMP production in systemic organs, 
providing an important signaling role in mammalian biology [10], dietary nitrate/nitrite also transmit 
biological signals via cGMP-independent mechanisms, such as t ransnitrosylation, a posttranslational 
modification analogous to phosphorylation, in order to regulate the protein function [40] (Figures 1 and 3). 
Here, the questions are raised. What is the carrier of NO activity to the peripheral organs,  
S-nitrosothiol, NO itself, or nitrite, and also, how does this carrier transnitrosylate in the peripheral 
organs? Lundberg et al., showed that oral intake of sodium nitrate (10 mg/kg) in healthy  
volunteers significantly increased plasma levels of nitrite, but did not increase S-nitrosothiol in  
plasma [20] (Table 2). In addition, Bryan et al., showed that protein S-nitrosylation in organs  
following intraperitoneal nitrite injection to rat, could not be inhibited by NO scavenging  
with carboxy-2-phenyl-4,4,5,5-tetramethylimidazolin-1-oxyl-3-oxide (cPTIO), suggesting that the  
nitrite-mediated transnitrosylation in the organs might occur mainly directly through nitrite rather than 
through either circulating S-nitrosothiol or NO itself [10]. 
Bryan et al., also showed that the increase in plasma nitrite within the physiological concentration 
rage of 0.2–2 μM after nitrite administration (plasma concentration of nitrite far lower than those 
required for vasodilation) enhanced S-nitrosothiol in the organs (heart, kidney, liver, lung, and aorta) 
with the subsequent modulation of signaling and gene expressions of cGMP, cytochrome P-450, heat 
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shock protein 70, and heme oxygenase-1 in these organs. Interestingly, they also showed that a switch 
of the standard chow to the low nitrate/nitrite diet for two days in rats decreased nitrite levels 
substantially in all tissues and represented changes of the signaling and gene expressions in a direction 
opposite to those found with nitrite administration [10]. 
These observations indicate that the nitrite-induced transnitrosylation in organs might be an 
alternative in vivo nitrite signaling for the mammalian biology including protection of protein thiols 
from irreversible oxidation, transcriptional modulation, and posttranslational regulation of most classes 
of proteins present in all cells [9] (Figure 3), and also that changes in plasma nitrite levels even within 
the physiological ranges (e.g., postprandial and fasting) can affect tissue levels of S-nitrosothiol and 
subsequent cellular biology. 
 
Figure 3. Protein S-nitrosylation. S-nitrosylation of protein elicits its regulatory effect 
by adding the NO moiety on the active thiol (SH of cysteine residue) of the protein  
(e.g., transcriptional factors and enzymes), and cell protection by the subsequent 
posttranslational addition of glutathione to the protein thiols (so-called glutathione cap), 
which shields the cysteine residues from further irreversible protein oxidation [11]. 
3. Safety and Efficacy of Dietary Nitrate 
Very high concentrations of nitrate in drinking water may cause methemoglobinemia in infants 
(blue baby syndrome) [41]. In the 1940s, Comly first reported cases of cyanotic infants who received 
formula prepared with well water containing a high nitrate content [42]. Based on t he subsequent 
analyses of the infantile cases o f methemoglobinemia, the US Environmental Protection Agency 
(EPA) set a Maximum Contaminant Level (MCL) for nitrate of 44 mg/L (equal to 10 mg/L nitrogen in 
nitrate). However, it is now thought that methemoglobinemia per se was not caused by nitrate itself, 
but by fecal bacteria that infected infants and produced NO in their gut. A recent report by Avery has 
argued that it is unlikely that nitrate causes methemoglobinemia without bacterial contamination, and 
also that the 40–50 mg/L limit on nitrate in drinking water is not necessary [43]. However, there are 
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now legal limits to the concentrations of nitrate and nitrite in both food and drinking water. The WHO 
showed that the Acceptable Daily Intake for humans (ADI) for nitrate and nitrite were 3.7 and  
0.07 mg/kg body w eight/day, respectively, which were based on t he calculations from the doses  
of <500 mg of sodium nitrate/kg body weight that were harmless to rats and dogs. The international 
estimates of nitrate intake from food are 31–185 mg/day in Europe and 40–100 mg/day in the United 
States [44,45]. However, the Ministry of Health, Labour and Welfare of Japan reported that the 
average intake of nitrate in the Japanese populations is around 200–300 mg/day, which is one and a 
half times to two times the ADI. Furthermore, according to a report by Hord [28], in which the daily 
nitrate and nitrite intakes were calculated based on the variations using the vegetable and fruit 
components of the DASH (Dietary Approaches to Stop Hypertension) dietary pattern [46], the level 
easily exceeds 1,200 mg/day nitrate. This is more than five-fold higher than the WHO’s ADI of 3.7 mg 
nitrate/kg body weight/day, and more than two-fold the US Environmental Protection Agency’s level 
of 7.0 mg nitrate/kg body weight/day for a 60 kg individual [28]. Furthermore, as indicated in Figure 2, 
approximately 25% of the ingested nitrate is secreted in saliva, and 20% of the secreted nitrate in 
saliva is converted to nitrite by commensal bacteria on the tongue [22], indicating that about 5% of the 
originally ingested nitrate is swallowed into the stomach (Figure 1). Therefore, for a DASH diet 
containing 1200 mg nitrate, an individual would be expected to swallow approximately 45 m g of 
nitrite a day, which easily exceeds the ADI of nitrite. Therefore, a comprehensive reevaluation of the 
health effects of dietary sources of nitrate/nitrite might be required in the near future [28]. Another 
major health concern regarding dietary nitrate/nitrite is whether dietary nitrate can cause cancer. In 
fact, nitrate and nitrite themselves are not carcinogenic, but nitrite which is formed from dietary nitrate 
might react with dietary amines to form carcinogenic nitrosoamines. This phenomenon will be 
discussed in detail below. 
4. Protective Effects of Dietary Nitrate/Nitrite on Lifestyle-Related Diseases 
Lifestyle-related disease is a chronic disease characterized by oxidative and proinflammatory state 
with reduced NO bioavailability [47]. The cellular redox balance in these patients shifts toward a more 
oxidizing state which affects a number of protein functions at the transcriptional and posttranslational 
levels, consequently disrupting the cellular homeostasis [11,40]. However, increased NO 
bioavailability can improve the intracellular redox environment by S-nitrosylation-mediated 
modulation of most classes of proteins present in all cells [9,40]. Recently, accumulating evidence has 
suggested that dietary nitrate/nitrite improves the features of lifestyle-related diseases by enhancing 
NO availability, and thus provides potential options for prevention and therapy for these patients [28]. 
Based on the recent evidence, the beneficial effects of a diet rich in these components are discussed 
below, focusing on i nsulin resistance, hypertension, cardiac ischemia/reperfusion injury, chronic 
obstructive pulmonary disease (COPD), cancer, and osteoporosis. 
4.1. Insulin Resistance 
The insulin receptor shares a si gnaling pathway with the activation of endothelial NOS  
(eNOS) [19,48–52] to regulate the postprandial blood flow and efficient nutrient disposition to 
peripheral tissues (Figure 4). Therefore, insulin resistance is always associated with impaired NO 
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availability, suggesting that a r eciprocal relationship exists between insulin activation and endothelial 
function [50,53]. Insulin resistance is improved by N O at various levels including insulin  
secretion [54,55], mitochondrial function [56], modulation of inflammation [57], insulin signaling [58] 
and glucose uptake [59]. For example, insulin-stimulated NO production has physiological 
consequences resulting in capillary recruitment and increased blood flow in skeletal muscle, leading to 
efficient glucose disposal [52]. 
 
Figure 4. The NO-mediated actions on insulin signaling pathway. The boxes with arrows 
indicate the sites of NO-mediated actions against insulin resistance. Dotted lines 
represent inhibition, and solid lines represent stimulation. (1) NO suppresses  
TLR4-mediated inflammation and ROS production; (2) NO enhances the effects of 
insulin through the S-nitrosylation-mediated inhibition of phosphatase activity of 
PTPB1; (3) NO-dependent nitrosylation of GLUT4 facilitates glucose uptake; (4) NO 
inhibits mitochondrial ROS production through S-nitrosylation of the mitochondrial 
respiratory chain complex. IRS-1: insulin receptor substrate-1, ROS: reactive oxygen 
species, NO: nitric oxide, eNOS: endothelial NO synthase, GLUT4: glucose transporter 
4, PI3 kinase: phosphatidylinositol 3-kinase, PTPB1: protein-tyrosine phosphatase B1, 
TLR4: toll like receptor 4. 
However, the most important mechanism to improve insulin resistance might be at the post-receptor 
level of insulin signaling [60] (Figure 4). In diabetic states, increased adiposity releases free fatty acids 
and produces excessive reactive oxygen species (ROS) through a toll-like receptor 4 (TLR4)-mediated 
mechanism, which activates a number of kinases and phosphatases [61], and then disrupts the balance 
of protein phosphorylation/dephosphorylation associated with insulin signaling [62]. The mechanisms 
underlying the NO-mediated beneficial effects on insulin resistance are as f ollows (Figure 4): First, 
NO suppresses the TLR4-mediated inflammation and ROS production by i nactivating IkB  
kinase-β/nuclear factor-κB (IκκB/NF-κβ) [9,63], the main trigger for the induction of a number of 
proinflammatory cytokines. Second, Wang et al., indicated that NO mediates the S-nitrosylation of 
protein-tyrosine phosphatase 1B (PTPB1) and enhances the effects of insulin [52]. Because PTPB1 
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dephosphorylates the insulin receptor and its substrates, attenuating the insulin effect, its phosphatase 
activity tends to be suppressed by eNOS-mediated S-nitrosylation. In contrast, when the vascular 
eNOS activity is impaired, PTPB1 suppresses the downstream signaling to PI3K/Akt, leading to 
insulin resistance. Therefore, NO might act as a key regulatory mediator for the downstream signaling 
linking glucose transporter 4 (GLUT4) translocation and glucose uptake [58,64]. Third, Jiang recently 
reported that NO-dependent nitrosylation of GLUT4 facilitates GLUT4 translocation to the membrane 
for glucose uptake, and improves insulin resistance [65]. Fourth, excess nutrients also overproduce 
superoxide in the mitochondrial respiratory chain, leading to the subsequent formation of ROS. NO can 
inhibit mitochondrial ROS production through the S-nitrosylation of mitochondrial respiratory chain 
complex 1 enzyme and by i mproving the efficiency of oxidative phosphorylation in the  
mitochondria [12]. 
Indeed, the therapeutic potential of dietary nitrate/nitrite has been supported by r ecent studies 
demonstrating the improvements of insulin resistance in humans and animals as a result of its  
enhancing the NO availability in plasma and tissues [65–68]. As mentioned above, insulin resistance  
always accompanies metabolic and endothelial dysfunction, which lead to hypertension and  
atherosclerosis [50,51,53,69,70]. Enhancement of the availability of NO might therefore be a promising 
strategy for the prevention and treatment of patients with not only insulin resistance, but also 
endothelial dysfunction [71]. 
4.2. Hypertension 
Increased consumption of fruits and vegetables is associated with a reduction of the risk of 
cardiovascular disease [72–74]. The DASH studies recommended the consumption of diets rich in 
vegetables and low-fat dairy products to lower blood pressure, and these effects are thought to be 
attributable to the high calcium, potassium, polyphenols and fiber and low sodium content in these 
food items [75,76]. However, vegetable diets containing high nitrate levels increase the plasma levels 
of nitrate and nitrite [77], which are the physiological substrates for NO production. Accumulating 
evidence has recently indicated that the nitrate/nitrite content of the fruits and vegetables could 
contribute to their cardiovascular health benefits in animals [29,33,78–83] and humans [31,84–86]. 
A number of publications have demonstrated that dietary nitrate reduces blood pressure in  
humans [87–89]. Larsen et al., reported that the diastolic blood pressure in healthy volunteers was 
reduced by dietary sodium nitrate (at a dose of 0.1 mmol/kg body weight per day) corresponding to the 
amount normally found in 150 to 250 g of a nitrate-rich vegetable, such as spinach, beetroot, or  
lettuce [84]. Webb et al., studied the blood pressure and flow-mediated dilation of healthy volunteers, 
and showed that the vasoprotective effects of dietary nitrate (a single dose of 500 mL of beetroot juice 
containing 45.0 ± 2.6 mmol/L nitrate), were attributable to the activity of nitrite converted from the 
ingested nitrate [86]. Kapil et al., also showed a similar finding that consuming 250 mL of beetroot 
juice (5.5 mmol nitrate) enhanced the plasma levels of nitrite and cGMP with a consequent  
decrease in blood pressure in healthy volunteers, indicating that there was soluble guanylate  
cyclase-cGMP-mediated vasodilation following a conversion of the nitrite to bioactive NO [85]. They 
later presented the effects of dietary nitrate on hypertension, and showed the first evidence that daily 
dietary nitrate supplementation (250 mL of beetroot juice daily) for four weeks reduced the blood 
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pressure, with improvements in the endothelial function and arterial stiffness in patients with 
hypertension [90]. Because arterial vascular remodeling is the major histological finding associated 
with aging, these vascular structural changes represent vascular wall fibrosis with increased collagen 
deposits and reduced elastin fibers, which result in arterial stiffening and subsequent hypertension in 
elderly patients. Sindler et al., recently demonstrated that dietary nitrite (50 mg/L in drinking water) 
was effective in the treatment of vascular aging in mice, which was evidenced by a reduction of aortic 
pulse wave velocity and normalization of NO-mediated endothelium-dependent dilation. They showed 
that these improvements were mediated by reduction of oxidative stress and inflammation, which were 
linked to mitochondrial biogenesis and health as a result of increased dietary nitrite. These beneficial 
effects were also evident with dietary nitrate in their study [91], suggesting that dietary nitrate/nitrite 
may be useful for the prevention and treatment of chronic age-associated hypertension. 
In addition, hypertension is also a major cause of ischemic heart and cardiac muscle remodeling, 
which lead to congestive heart failure. Bhushan et al., reported that dietary nitrite supplementation in 
drinking water (50 mg/L sodium nitrite, for nine weeks) increased the cardiac nitrite, nitrosothiol, and 
cGMP levels, which improved the left ventricular function during heart failure in mice with 
hypertension produced by t ransverse aortic constriction. They also showed that dietary nitrite 
improved the cardiac fibrosis associated with pressure-overloaded left ventricular hypertrophy through 
NO-mediated cytoprotective signaling [92]. Although a number of studies on t he acute effects of 
dietary nitrate have been conducted using animal models and healthy humans, more evidence in 
patients with hypertension, as well as additional studies on the long-term effects of dietary nitrate, will 
be needed in the future. 
4.3. Cardiac Ischemia/Reperfusion Injury 
During heart ischemia, ATP is progressively depleted in cardiac muscle cells, which impairs ion 
pumps, leads to the accumulation of calcium ion, and consequently damages the cell membrane 
stability. On reperfusion, the cardiac muscle cells are further injured, because in the mitochondria, 
ROS are produced in large quantities due to massive electron leaks and the formation of superoxide 
with the resupplied oxygen, which denatures cytosolic enzymes and destroys cell membranes by lipid 
peroxidation. ROS-mediated dysfunction of the sarcoplasmic reticulum also induces massive 
intracellular calcium overload, leading to the opening of the mitochondrial permeability transition pore 
and causing cell apoptosis or necrosis, depending on t he intracellular ATP levels [93,94]. The 
availability of vascular NO would thus be expected to be impaired due to the reduced NOS activity in 
ischemia and subsequent consumption by s uperoxide during reperfusion [95], resulting in severe 
ischemia/reperfusion injury [30]. 
Nitrite, nitrate, and NO-related compounds (e.g., S-nitrosothiols) are constitutively present in blood 
and tissues. The nitrite level in cardiac tissue is a couple of times higher than that in plasma due to an 
unknown form of active transport from blood to tissues or due to the oxidation of endogenously 
generated-NO to nitrite by ceruloplasmin [96], and serves as a significant extravascular pool for NO 
during tissue hypoxia [97]. Carlström et al., showed that dietary nitrate increased the tissue levels of 
nitrite and S-nitrosothiols in the heart, and attenuated oxidative stress and prevented cardiac injury in 
Sprague-Dawley rats subjected to unilateral nephrectomy and a high-salt diet [37]. Shiva et al., 
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recently showed that the nitrite stored in the heart and liver via systemic and oral routes augmented the 
tolerance to ischemia/reperfusion injury in the mouse heart and liver [33]. 
Although the genetic overexpression of eNOS in mice attenuates myocardial infarction [98], in 
general, the protective effects of NO on cardiac ischemia/reperfusion injury depend on the local stock 
of nitrite and its subsequent reduction to NO at the critical moment when NOS activity is lacking under 
hypoxic conditions. Indeed, the tissue levels of S-nitrosothiols (NO-mediated signaling molecules) are 
enhanced through the nitrite reduction due to NOS inhibition, hypoxia, and acidosis [97], suggesting 
that the tissue nitrite stores can be regarded as a backup and on-demand NO donor. There are a number 
of factors that have been demonstrated to reduce nitrite in the tissues, including deoxyhemoglobin, 
deoxymyoglobin, xanthine oxidoreductase, heme-based enzymes in the mitochondria and acidosis 
during ischemia [99,100]. In patients with coronary heart disease, the different consequences of 
myocardial infarction may depend on the patient’s daily intake of nitrate/nitrite. Indeed, Bryan et al., 
showed that dietary nitrite (50 mg/L) or nitrate (1 g/L) supplementation in drinking water for seven 
days maintained higher steady-state levels of nitrite and nitroso compounds, as well as nitrosyl-heme, 
in mouse cardiac muscle, and these mice exhibited a sm aller cardiac infarct size after 
ischemia/reperfusion injury compared with control mice fed a diet deficient in nitrate/nitrite for seven 
days. These findings suggest that this protective nitrate/nitrite may be derived at least in part from 
dietary sources [29]. 
Shiva et al., demonstrated that the cytoprotective effects of nitrite on ischemia/reperfusion injury 
are mediated by post-translational S-nitrosylation of complex 1 in the mitochondrial respiratory chain, 
which consequently inhibits the overall mitochondrial ROS formation and apoptotic events [101]. 
Another possible cytoprotective effects of nitrite may be mediated by the effects of S-nitrosylation on 
the intracellular Ca2+ handling, which decreases Ca2+ entry by i nhibiting L-type Ca2+ channels and 
increasing the sarcoendoplasmic reticulum (SR) Ca2+ uptake by activating SR Ca2+ transport ATPase 
(SERCA2a) [102]. These effects will lead to an attenuation of the increase in cytosolic Ca2+ during 
ischemia and Ca2+ overload during reperfusion. 
Intriguingly, recent large-scale epidemiological studies reported the preventive effects of 
antioxidant supplementations including vitamins E, C, and beta carotene rich in fruits and vegetables on 
cardiovascular disease, whereas no beneficial effects were shown in other studies, and in some cases a 
decrease in cardiovascular protection with these supplementations was observed [103–105]. On the 
other hand, a number of epidemiological studies have shown the preventive effects of fruits and 
vegetables on coronary heart disease [3–6,106]. It should be noted that the consumption of an 
appropriate amount of fruits and vegetables, which might contain balanced doses of nitrate/nitrite and 
vitamins, might be more effective with regard to health maintenance and improvement than 
antioxidant supplementation alone. 
4.4. Chronic Obstructive Pulmonary Disease (COPD) 
COPD is considered to be a l ifestyle-related disease, because long-term tobacco smoking and 
subsequent chronic bronchitis are causally associated with this disease [107]. Varraso et al., recently 
reported the importance of a healthy diet in multi-interventional programs to prevent COPD [108].  
They showed that high intake of whole grains, polyunsaturated fatty acids, nuts, and long chain omega-3 
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fats, and low intake of red/processed meats, refined grains and sugar-sweetened drinks, were 
associated with a lower risk of COPD in both women and men. 
Because cured meats such as bacon, sausage and ham contain high doses of nitrite for preservation, 
antimicrobial and color fixation, epidemiological studies have demonstrated that the consumption of 
cured meats is positively linked to the risk of newly diagnosed COPD [109–111]. Nitrite generates 
reactive nitrogen species, which may cause nitrosative damage to the lungs, eventually leading to 
structural changes like emphysema [111]. This is supported by a n animal study in which rats 
chronically exposed to 2000 and 3000 mg/L of sodium nitrite in their drinking water for two years 
showed distinct lung emphysema [112]. However, the dose of nitrite used in that study was  
250–350 mg/kg/day, which was too high to compare with those achieved in standard human  
diets [113]. 
In fact, cured meats have been reported to generally comprise only 4.8% of the daily nitrite intake, 
and surprisingly, 93% of the total ingestion of nitrite is derived from saliva [114], suggesting that 
cured meats provide minimal contributions to the human intake of nitrite, even if they are frequently 
consumed. In addition, the recent nitrite levels in processed meats have been approximately 80% lower 
than those in the mid-1970s in the US [115]. Therefore, discussions encompassing all ingested sources 
of nitrite should consider whether or not the nitrite derived only from the consumption of cured meats 
might be responsible for the development of COPD. 
On the other hand, a number of epidemiological studies have shown the beneficial effects of  
n-3 fatty acids, vitamins, fruits and vegetables on lung functions and the risk of COPD [108,116–122]. 
Although it may be difficult to isolate the specific effects of these dietary nutrients, as discussed above, 
the nitrate and nitrite derived from vegetables and fruits are reduced to NO, which is followed by the 
formation of S-nitrosothiols [123], rather than the formation of nitrosamines especially in the presence 
of reducing agents such as vitamin C and E in the stomach [28,124]. It has been shown that high 
dietary nitrate intake does not cause the expected elevation of the gastric nitrite concentrations or 
appreciable changes in the serum nitrite concentrations [125]. 
As mentioned above, different from the effects of the direct elevation of nitrite concentration in the 
plasma, the entero-salivary route of dietary nitrate/nitrite might enhance the availability of NO through 
the formation of S-nitrosothiols and its transnitrosylation to the other thiol residues of proteins, 
suggesting that, depending on the tissues and organs, separate metabolic pathways might exist for NO 
availability in this entero-salivary route. Consistent with this idea, Larsen et al., recently demonstrated 
that acute intravenous infusion of nitrite enhanced the plasma levels of nitrite, whereas it did not affect 
the oxygen consumption (VO2) or the resting metabolic rate (RMR) in humans. Instead, dietary nitrate 
significantly reduced the VO2 and RMR by improving the mitochondrial respiratory chain function and 
enhancing efficient O2 consumption, suggesting that rather than direct nitrite infusion to enhance the 
plasma nitrite levels, biologically active nitrogen oxide (including the S-nitrosothiols produced in the 
stomach) might be an important molecule for the transfer of biological NO activity for 
cardiopulmonary function [126]. Because COPD is a st ate of protein-energy malnutrition due to an 
increased resting metabolic rate and VO2, the effects of dietary nitrate on the reduction of the RMR 
and VO2 might be advantageous for patients with COPD. 
Whether the role of NO in COPD is protective or pathogenic depends on t he origin and 
concentration range of NO. NO activity derived from dietary nitrate and constitutive NOS might be 
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protective against COPD largely through the S-nitrosothiol-mediated mechanism including inhibition 
of the noncholinergic nonadrenergic nerve activity, bronchial smooth muscle relaxation, reduction of 
airway hyperresponsiveness, downregulation of the proinflammatory activity of T lymphocytes, and 
antimicrobial defense [127]. However, the deleterious effects of NO on the development of COPD 
might be derived from iNOS-mediated pro-inflammatory signaling [128], which is consequently (not 
causally) reflected by the huge amount of NO in the exhaled air of patients with COPD [129]. 
Recent human studies have demonstrated that dietary nitrate (beetroot juice containing 
approximately 200–400 mg of nitrate) improved the exercise performance and reduced blood pressure 
in COPD patients [130,131]. However, large-scale epidemiological evidence of the impact of nitrate is 
still lacking. 
4.5. Cancer 
In the stomach, swallowed nitrite is decomposed to form a variety of nitrogen compounds, 
including N-nitrosoamines [132]. In the 1950s, Magree et al., first reported that  
N-nitrosodimethylamine caused malignant primary hepatic tumors in rats [133]. After this report, a 
number of studies followed in relation to the carcinogenic effects of N-nitroso compounds in animal 
models [134,135]. In particular, the dietary intake of red and cured meats was found to be associated 
with an increased risk of certain types of cancer due to the relatively large amounts of nitrite added. 
However, the methodological aspects have been challenged concerning the high dose of nitrosatable 
amines, and the physiological difference between animals and humans [136]. 
In the stomach, the nitrosonium ion (NO+) derived from nitrite can bind to thiol compounds (R-SH) 
and amines (especially secondary amines: R1-NH-R2), forming S-nitrosothiol and N-nitrosamine, 
respectively. However, while N-nitrosamine formation occurs even at neutral or basic pH,  
S-nitrosothiol formation tends to occur only under acidic conditions. In addition, this reaction 
kinetically occurs much more easily than N-nitrosamine formation, particularly in the presence of 
vitamins C and E and polyphenols, which are highly present in fruits and vegetables, which also 
eliminate potent nitrosating agents such as the N2O3 formed from nitrite by decomposing them to NO. 
This might partly explain why patients with achlorhydria and non-vegetarians eating large amounts of 
cured meats are at risk of developing gastric cancer [137–142]. 
However, this idea appears to be inconsistent with the belief that dietary nitrite is a major cause of 
cancer. This is because, according to the average nitrate/nitrite intake of adults in the US, most of the 
daily nitrate intake (around 90%) comes from vegetables, and the nitrite intake is primarily derived 
from recycled nitrate in the saliva (5.2–8.6 mg/day nitrite), with very little coming from cured meats  
(0.05–0.6 mg/day nitrite in 50g/day cured meats) and other dietary sources (0–0.7 mg/day  
nitrite) [136], suggesting that the entero-salivary route may be the more important source of 
nitrosamine exposure than exogenous intake including cured meats, that is, spitting out saliva all day 
long might prevent cancer development more effectively than cutting cured meats. However, recent 
experimental and epidemiological studies could not demonstrate a positive relationship between nitrate 
consumption and the risk of cancer [121,134], and the Joint Food and Agriculture Organization/World 
Health Organization Expert Committee on F ood Additives concluded in 2008 that there was no 
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evidence that nitrate was carcinogenic in humans. Consistent with this, recent studies have found no 
link between dietary nitrate and cancer [143,144]. 
Bradbury et al., reported a large-scale study (>500,000 participants) of the associations between 
fruit, vegetable, or fiber consumption and the risk of cancer at 14 di fferent sites. They showed that 
there was an inverse association between fruit intake and the risk of upper gastrointestinal tract and 
lung cancer, as well as an inverse association between fiber intake and liver cancer. The dietary intake 
of vegetables, as well as fruits and fiber, was inversely associated with the risk of colorectal cancer, 
suggesting that there is little evidence that vegetable intake is associated with the risk of any of the 
individual cancer sites reviewed [145].  
However, chronic inflammation, including inflammatory bowel disease and Helicobacter  
pylori-induced gastritis induce inducible NOS (iNOS) and generate large quantities of  
NO [22,146,147], forming nitrosating and oxidant species such as N2O3 and peroxynitrite, which might 
cause mutagenesis through deamination, nitration of DNA, or inhibition of the DNA repair  
system [148,149]. Depending on t he sites and amounts of NO generation, NO might represent a 
double-edged sword in the sense that it confers both protective and deleterious effects on cancer  
development [150,151]. 
Meta-analyses of primary and secondary cancer prevention trials of dietary antioxidant 
supplements, such as beta carotene, vitamins A, C, and E, showed a lack of efficacy, and on the 
contrary, an increased risk of mortality [104]. Although the general role of NO in carcinogenesis is 
complicated, and many unknown mechanisms remain to be resolved, the dietary nitrate/nitrite (at least 
that obtained from plant-based foods such as fruits and vegetables) have obvious inhibitory effects on 
cancer risk by playing some synergistic role with other nutrients in these foods. 
4.6. Osteoporosis 
Lifestyle habits, such as smoking, alcohol intake, little or no exercise, and an inadequate amount of 
calcium intake all influence the calcium-vitamin D metabolism [152–155] and bone mineral density,  
in some cases leading to osteoporosis, particularly in postmenopausal women [156]. The implications 
of NOS-mediated NO in the regulation of bone cell function have been well described in a number of 
publications [157]. For example, iNOS-induced NO production following stimulation with 
proinflammatory cytokines, such as interleukin 1 (IL-1) and tumor necrosis factor-α (TNF-α), inhibits 
bone resorption and formation, resulting in osteoporosis in patients with inflammatory diseases such as 
rheumatoid arthritis [158]. On the other hand, eNOS, a constitutive NO synthase, plays an important role 
in regulating osteoblast activity and bone formation, because eNOS knockout mice exhibit 
osteoporosis due to defective bone formation, and eNOS gene polymorphisms were reported to be 
causally linked to osteoporosis in postmenopausal women [159].  
In addition, Wimalawansa et al., showed that some of the beneficial effects of estrogen on bone 
metabolism are mediated through a NO-cGMP-mediated pathway [160], suggesting that NO donor 
therapy might provide a promising alternative to estrogen therapy. In this context, it has been shown 
that organic nitrate NO donors, such as glycerol trinitrate, isosorbide dinitrate and mononitrate all have 
beneficial effects on experimental and clinical osteoporosis [161–163], and a number of 
epidemiological studies also indicated that a high fruit and vegetable intake appears to have a 
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protective effect against osteoporosis in men and pre- and postmenopausal women [164–166]. 
However, few studies have been conducted to evaluate the detailed mechanism by which inorganic 
nitrate/nitrite prevents osteoporosis at the molecular level, and thus further basic research will be 
needed for this purpose. 
5. Conclusions 
Dietary nitrate, which is provided by fruits and vegetables, can transmit NO activities in various 
molecular forms, including NO, nitrite, and S-nitrosothiols, through the entero-salivary pathway. 
Although the role of diet-derived NO activity in lifestyle-related diseases is complex and remains to be 
fully elucidated, the intake of nitrate as a nutrient in vegetables might be beneficial to human health as 
a result of synergistic effects with other nutrients present in vegetables, and would be recommended as 
a nutritional approach to the prevention and treatment of the lifestyle related diseases. 
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